Time-staggered delivery of docetaxel and H1-S6A,F8A peptide for sequential dual-strike chemotherapy through tumor priming and nuclear targeting
Authors:
- 1 June 2016
- journal article
- Published by Elsevier in Journal of Controlled Release
- Vol. 232, 62-74
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (81473167)
- Ministry of Education of the People's Republic of China (2013018111001)
This publication has 52 references indexed in Scilit:
- A smart polymeric platform for multistage nucleus-targeted anticancer drug deliveryBiomaterials, 2015
- A Strategy for Combating Melanoma with Oncogenic c-Myc Inhibitors and Targeted NanotherapyNanomedicine, 2015
- Combinational delivery of c-myc siRNA and nucleoside analogs in a single, synthetic nanocarrier for targeted cancer therapyBiomaterials, 2013
- MSN Anti‐Cancer Nanomedicines: Chemotherapy Enhancement, Overcoming of Drug Resistance, and Metastasis InhibitionAdvanced Materials, 2013
- The intranuclear release of a potential anticancer drug from small nanoparticles that are derived from intracellular dissociation of large nanoparticlesBiomaterials, 2012
- Functional genomics identifies therapeutic targets for MYC-driven cancerProceedings of the National Academy of Sciences, 2012
- MYC on the Path to CancerCell, 2012
- Mediating Tumor Targeting Efficiency of Nanoparticles Through DesignNano Letters, 2009
- Targeting a c-Myc inhibitory polypeptide to specific intracellular compartments using cell penetrating peptidesJournal of Controlled Release, 2009
- Sustained Loss of a Neoplastic Phenotype by Brief Inactivation of MYCScience, 2002